Cellular Proliferation and Reprogramming in Pre‐Metastatic Niches: Mechanisms and Therapeutic Vulnerabilities
Cell Proliferation · 2026-11-10
DOI: 10.1111/cpr.70296 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2026-11-10. Written by Shengqian Wang and 14 co-authors. Institution: First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China. 350 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Jiangsu Province, Natural Science Research General Program of Jiangsu Higher Education Institutions, Youth Talent Project of Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan.
Abstract (original language)
Cancer metastasis, the leading cause of cancer‐related mortality, fundamentally depends on the proactive remodelling of distant organ microenvironments by primary tumours through systemic signals, creating a pre‐metastatic niche before tumour cell arrival. This review systematically deconstructs the dynamic spatiotemporal evolution of the pre‐metastatic niche, highlighting the multi‐layered reprogramming of stromal, endothelial and immune cells that collectively cultivate a pro‐tumourigenic and immunosuppressive microenvironment. We elucidate the biomechanical and biochemical sensing mechanisms, derived primarily from experimental models, that dictate the fate of disseminated tumour cells, governing the critical balance between dormancy maintenance and proliferative reactivation. Furthermore, we synthesize mechanistic insights alongside human tissue and liquid‐biopsy correlative evidence on how metabolic resetting and epigenetic memory may contribute to sustaining pre‐metastatic niche stability, and discuss how cutting‐edge single‐cell and spatial omics technologies are deciphering the intricate multicellular topological architecture of the niche. Ultimately, by mapping these complex systemic interactions across preclinical, biomarker and translational levels, we identify potential therapeutic vulnerabilities and advocate for a paradigm shift toward microenvironment normalization. While clinical validation remains an evolving frontier, targeting pre‐metastatic niche priming represents a promising window that warrants rigorous clinical evaluation to intercept nascent metastasis before clinically detectable colonization occurs.
Subjects
Author keywords
Authors and institutions
- First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Thoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
- Department of Clinical Laboratory, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
- College of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory, Chongqing Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing, China.
ORCID profiles: Shengqian Wang, Pengfei Li, Xinyan Zhang, Yang Luo, Xiaohui Fan, Yang Zhang, Wenjun Mao
Funding
- Natural Science Foundation of Jiangsu Province
- Natural Science Research General Program of Jiangsu Higher Education Institutions
- Youth Talent Project of Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan
- Luo Linxiu Faculty Development Fund of Nanjing University of Chinese Medicine
- Natural Science Foundation Project of Nanjing University of Chinese Medicine
Cite
APA
Wang, S., Song, C., Li, P., Feng, J., Shi, X., Lu, Q., Duan, B., Zhang, X., Li, S., Luo, Y., Fan, X., Li, Z., Zhang, Y., Gu, R., & Mao, W. (2026). Cellular Proliferation and Reprogramming in Pre‐Metastatic Niches: Mechanisms and Therapeutic Vulnerabilities. Cell Proliferation. https://doi.org/10.1111/cpr.70296
Vancouver
Wang S, Song C, Li P, Feng J, Shi X, Lu Q, et al. Cellular Proliferation and Reprogramming in Pre‐Metastatic Niches: Mechanisms and Therapeutic Vulnerabilities. Cell Proliferation. 2026. doi:10.1111/cpr.70296
BibTeX
@article{Wang2026,
author = {Wang, Shengqian and Song, Chenghu and Li, Pengfei and Feng, Junjie and Shi, Xiaoxuan and Lu, Qiwen and Duan, Bohan and Zhang, Xinyan and Li, Siqi and Luo, Yang and Fan, Xiaohui and Li, Ziyun and Zhang, Yang and Gu, Renjun and Mao, Wenjun},
title = {Cellular Proliferation and Reprogramming in Pre‐Metastatic Niches: Mechanisms and Therapeutic Vulnerabilities},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70296}
}
EUVIMED